Age-dependent administration and survival benefit of androgen deprivation therapy (ADT) vs. chemotherapy plus ADT (C+ADT) in metastatic prostate cancer (mPC)

Autor:	Shiva Kumar Reddy Mukkamalla, Andre Desouza, Nishitha Reddy, Lisa Giscombe, Ritesh Rathore, Matthew Keating
Rok vydání:	2018
Předmět:	Oncology Cancer Research Chemotherapy medicine.medical_specialty Standard of care business.industry medicine.medical_treatment Age dependent medicine.disease Androgen deprivation therapy Prostate cancer Survival benefit immune system diseases Internal medicine medicine business
Zdroj:	Journal of Clinical Oncology. 36:e17046-e17046
ISSN:	1527-7755 0732-183X
Popis:	e17046Background: ADT remains the standard of care in treatment of mPC. Two key prospective trials over the past few years have implored addition of chemotherapy to ADT. We assessed overall surviva...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4edff83cfa8f5c641046d38ee285bbbe https://doi.org/10.1200/jco.2018.36.15_suppl.e17046 Zobrazit plný text záznamu